Analysis of Bcl-2 Protein Expression in Chronic Lymphocytic Leukemia-Reference-Cited by-同舟云学术

Analysis of Bcl-2 Protein Expression in Chronic Lymphocytic Leukemia

Published:2000-02-01 Issue:2 Volume:113 Page:219-229
ISSN:1943-7722
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Marschitz Ingrid¹,Tinhofer Inge¹,Hittmair Anton²,Egle Alexander¹,Kos Marion¹,Greil Richard¹

Affiliation:

1. Department of Internal Medicine, Laboratory of Molecular Cytology, University of Innsbruck, Austria

2. Department of Pathology, University of Innsbruck, Austria

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/113/2/219/24980462/ajcpath113-0219.pdf

Reference46 articles.

1. Tsujimoto Y, Finger LR, Yunis J, et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 1984;226: 1097-1099.

2. Chao DT, Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu Rev Immunol. 1998;16:395-419.

3. Castle VP, Heidelberger KP, Bromberg J, et al. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol. 1993;143:1543-1550.

4. Lipponen P, Pietilainen T, Kosma VM, et al. Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J Pathol. 1995;177:49-55.

5. Charpin C, Garcia S, Bonnier P, et al. bcl-2 automated and quantitative immunocytochemical assays in breast carcinomas: correlation with 10-year follow-up. J Clin Oncol. 1998;16:2025-2031.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow cytometric expression of Bcl-2, Mcl-1, and their ratios correlates with primary and secondary cytogenetic changes and their combinations in multiple myeloma;Annals of Hematology;2024-09-12

2. Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation;Heliyon;2024-02

3. The Historical Relationship Between Meis1 and Leukemia;Advances in Experimental Medicine and Biology;2022

4. The Role of BTK Inhibition in the Treatment of Chronic Lymphocytic Leukemia: A Clinical View;Journal of Experimental Pharmacology;2021-10

5. Safety and efficacy of navitoclax, a BCL-2 and BCL-XL inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study;Leukemia & Lymphoma;2020-11-25